COPD therapy

BREO ELLIPTA Will Help Patients Breathe Better Day-to-Day
May 14, 2013
GlaxoSmithKline (GSK) and Theravance have announced the FDA approval of Breo Ellipta as maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD) patients. The inhaled long-term, once-daily maintenance ...

Tags: GSK, Theravance, Copd Therapy
GlaxoSmithKline and Theravance Have Announced The MAA Submission for Anoro
Jan 11, 2013
GlaxoSmithKline and Theravance have announced the MAA submission for Anoro in Europe for patients with chronic obstructive pulmonary disease (COPD). The COPD therapy, administered using the ELLIPTA inhaler, is a combination of GSK573719 ...

Tags: GlaxoSmithKline, COPD therapy, chronic obstructive pulmonary disease
Astellas and AstraZeneca Announced Approval of Dry-Power Inhaler Symbicort Turbuhaler
Nov 28, 2012
Astellas Pharma and AstraZeneca have announced the approval of the dry-power inhaler Symbicort Turbuhaler for the additional indication of chronic obstructive pulmonary disease(COPD). Symbicort Turbuhaler is a combination product ...

Tags: Astellas Pharma, AstraZeneca, dry-power inhaler Symbicort Turbuhaler